Literature DB >> 21177893

Detection of fluoroquinolone-resistant organisms from rectal swabs by use of selective media prior to a transrectal prostate biopsy.

Michael A Liss1, Amy N Peeples, Ellena M Peterson.   

Abstract

Sepsis caused by fluoroquinolone-resistant Escherichia coli is a risk for patients undergoing an ultrasound-guided, transrectal prostate biopsy. A method incorporating selective broth and media was evaluated using rectal swabs obtained from 136 patients prior to a biopsy procedure. Fluoroquinolone-resistant organisms were isolated from 22% of the patients included in this study.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21177893      PMCID： PMC3067719          DOI： 10.1128/JCM.01885-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract.

Authors:  Ebbing Lautenbach; Anthony D Harris; Eli N Perencevich; Irving Nachamkin; Pam Tolomeo; Joshua P Metlay
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

2.  Best practice policy statement on urologic surgery antimicrobial prophylaxis.

Authors:  J Stuart Wolf; Carol J Bennett; Roger R Dmochowski; Brent K Hollenbeck; Margaret S Pearle; Anthony J Schaeffer
Journal:  J Urol       Date:  2008-02-20       Impact factor: 7.450

3.  Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy.

Authors:  Deepak Batura; G Gopal Rao; Peder Bo Nielsen
Journal:  BJU Int       Date:  2010-03-16       Impact factor: 5.588

4.  Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy.

Authors:  Raanan Tal; Pinhas M Livne; Dov M Lask; Jack Baniel
Journal:  J Urol       Date:  2003-05       Impact factor: 7.450

5.  Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.

Authors:  Ebbing Lautenbach; Neil O Fishman; Joshua P Metlay; Xiangqun Mao; Warren B Bilker; Pam Tolomeo; Irving Nachamkin
Journal:  J Infect Dis       Date:  2006-05-31       Impact factor: 5.226

6.  The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?

Authors:  Joseph Feliciano; Ervin Teper; Michael Ferrandino; Richard J Macchia; William Blank; Ivan Grunberger; Ivan Colon
Journal:  J Urol       Date:  2008-01-22       Impact factor: 7.450

7.  Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis.

Authors:  J Carratala; A Fernandez-Sevilla; F Tubau; M A Dominguez; F Gudiol
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

8.  Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries.

Authors:  S Nys; I N Okeke; S Kariuki; G J Dinant; C Driessen; E E Stobberingh
Journal:  J Antimicrob Chemother       Date:  2004-10-07       Impact factor: 5.790

9.  Prevalence and risk factors for selection of quinolone-resistant Escherichia coli strains in fecal flora of patients receiving quinolone therapy.

Authors:  D Yagci; F Yoruk; A Azap; O Memikoglu
Journal:  Antimicrob Agents Chemother       Date:  2008-12-08       Impact factor: 5.191

10.  Ultrasound guided transrectal core biopsies of the palpably abnormal prostate.

Authors:  K K Hodge; J E McNeal; T A Stamey
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450
View more
  10 in total

1.  Chemoprophylaxis during transrectal prostate needle biopsy: critical analysis through randomized clinical trial.

Authors:  Ahmed M Elshal; Ahmed M Atwa; Ahmed R El-Nahas; Mohamed A El-Ghar; Asaad Gaber; Essam Elsawy; Abdelwahab Hashem; Yasser Farag; Hashim Farg; Ali Elsorougy; Mohamed Fouda; Hossam Nabeeh; Ahmed Mosbah
Journal:  World J Urol       Date:  2018-05-07       Impact factor: 4.226

2.  Antibiotic prophylaxis for transrectal ultrasound biopsy of the prostate in Ireland.

Authors:  L G Smyth; D W Mulvin
Journal:  Ir J Med Sci       Date:  2011-11-06       Impact factor: 1.568

3.  Reply by Authors: "Prospective Monitoring and Adapting Strategies for Prevention of Infection Following Transrectal Prostate Procedures".

Authors:  Solomon L Woldu; Ryan C Hutchinson; Nirmish Singla; Brad Hornberger; Claus G Roehrborn; Yair Lotan
Journal:  Urol Pract       Date:  2018-03

4.  Rectal E. coli above ciprofloxacin ECOFF associate with infectious complications following prostate biopsy.

Authors:  Inari Kalalahti; Kaisa Huotari; Kanerva Lahdensuo; Eveliina Tarkka; Henrikki Santti; Antti Rannikko; Anu Pätäri-Sampo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-02       Impact factor: 3.267

5.  Comparison of broth enhancement to direct plating for screening of rectal cultures for ciprofloxacin-resistant Escherichia coli.

Authors:  Michael A Liss; Kristen K Nakamura; Ellena M Peterson
Journal:  J Clin Microbiol       Date:  2012-11-14       Impact factor: 5.948

6.  Emergency hospital admissions attributable to infective complications of prostate biopsy despite appropriate prophylaxis: need for additional infection prevention strategies?

Authors:  G Gopal Rao; Deepak Batura
Journal:  Int Urol Nephrol       Date:  2013-08-10       Impact factor: 2.370

7.  Incidence of infectious complications following transrectal ultrasound-guided prostate biopsy in Calgary, Alberta, Canada: A retrospective population-based analysis.

Authors:  Jan Krzysztof Rudzinski; Jun Kawakami
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

8.  Bacterial Urinary Tract Infection after Transrectal Placement of Fiducial Markers prior to Proton Radiotherapy for Prostate Cancer.

Authors:  William M Mendenhall; Gabriella Glassman; Christopher G Morris; Joseph A Costa; Christopher R Williams; Stephanie E Harris; Stephen E Mandia; Bradford S Hoppe; Randal H Henderson; Curtis M Bryant; R Charles Nichols; Nancy P Mendenhall
Journal:  Int J Part Ther       Date:  2016-08-29

9.  Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.

Authors:  Kyung Chul Son; Ho Seok Chung; Seung Il Jung; Myung Soo Kim; Eu Chang Hwang; Jin Woong Kim; Dong Deuk Kwon
Journal:  J Korean Med Sci       Date:  2018-04-09       Impact factor: 2.153

10.  Author'S reply.

Authors:  Przemysław Adamczyk
Journal:  Cent European J Urol       Date:  2013
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.